SCHEMBL20334422

SCHEMBL20334422

CCN1CCN(C(C)C)C(C)(C(F)(F)F)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20314968 0.77 — —
SCHEMBL20161741 0.76 TSHR (0.31) —
SCHEMBL24035086 0.71 TSHR (0.33) —
SCHEMBL21725612 0.68 — —
SCHEMBL25090320 0.68 TSHR (0.32) —
SCHEMBL24091632 0.68 TSHR (0.32) —
SCHEMBL20314975 0.67 TEAD1 (0.36) —
SCHEMBL20205750 0.66 TSHR (0.39) —
SCHEMBL23735852 0.64 — —
SCHEMBL24322203 0.63 TSHR (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018119183-A2 KRAS G12C INHIBITORS AND METHODS OF USING THE SAME AMGEN INC. (US) 2018-06-28 — — WO disclosed
Send feedback